Psychemedics Corporation (PMD)
NASDAQ: PMD
· Real-Time Price · USD
2.67
0.00 (0.00%)
At close: Jun 17, 2025, 10:00 PM
Psychemedics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 4.42M | 5.17M | 4.73M | 5.36M | 5M | 5.7M | 5.54M | 5.86M | 5.7M | 6.52M | 6.51M | 6.51M | 6.44M | 6.67M | 6.09M | 5.71M |
Cost of Revenue | 3.04M | 3.14M | 3.18M | 3.23M | 2.94M | 3.61M | 3.48M | 3.65M | 3.46M | 4.18M | 4.24M | 4.07M | 4.25M | 3.6M | 3.65M | 3.15M |
Gross Profit | 1.39M | 2.04M | 1.55M | 2.12M | 2.06M | 2.09M | 2.06M | 2.21M | 2.25M | 2.33M | 2.27M | 2.44M | 2.19M | 3.08M | 2.44M | 2.57M |
Operating Income | 168K | -595K | -899K | -567K | -868K | -1.11M | -417K | -528K | -356K | -375K | -342K | -10K | -965K | 850K | 207K | 117K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | 5K | n/a | 32K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 160K | -606K | -898K | -572K | -876K | -1.11M | -922K | -533K | -362K | -383K | -351K | 56K | -2.06M | 925K | 207K | 103K |
Net Income | 189K | -535K | -827K | -688K | -945K | -2.1M | -726K | -384K | -688K | -97K | -338K | 39K | -1.62M | 739K | 134K | 83K |
Selling & General & Admin | 1.04M | 2.46M | 2.26M | 2.48M | 2.64M | 2.92M | 2.19M | 2.44M | 2.28M | 2.38M | 2.26M | 2.13M | 2.84M | 1.98M | 1.94M | 2.17M |
Research & Development | 179K | 172K | 189K | 209K | 285K | 275K | 286K | 298K | 323K | 328K | 357K | 318K | 313K | 244K | 293K | 280K |
Other Expenses | n/a | n/a | n/a | -3K | -1K | n/a | -5K | -5K | -6K | -8K | -9K | n/a | n/a | n/a | n/a | -14K |
Operating Expenses | 1.22M | 2.63M | 2.45M | 2.69M | 2.93M | 3.2M | 2.48M | 2.73M | 2.6M | 2.71M | 2.62M | 2.45M | 3.15M | 2.23M | 2.23M | 2.45M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6K | 8K | 9K | n/a | 2.17M | n/a | n/a | 14K |
Selling & Marketing Expenses | 607K | 580K | 671K | 692K | 740K | 723K | 746K | 789K | 781K | 791K | 813K | 806K | 849K | 652K | 656K | 642K |
Cost & Expenses | 4.26M | 5.77M | 5.63M | 5.92M | 5.87M | 6.81M | 5.95M | 6.39M | 6.06M | 6.89M | 6.86M | 6.52M | 7.4M | 5.82M | 5.88M | 5.6M |
Income Tax Expense | -29K | -71K | -71K | 116K | 69K | 992K | -196K | -149K | 326K | -286K | -13K | 17K | -436K | 186K | 73K | 20K |
Shares Outstanding (Basic) | 5.89M | 5.89M | 5.82M | 5.81M | 5.81M | 5.75M | 5.71M | 5.68M | 5.73M | 5.64M | 5.61M | 5.59M | 5.59M | 5.54M | 5.54M | 5.54M |
Shares Outstanding (Diluted) | 5.89M | 5.89M | 5.82M | 5.81M | 5.81M | 5.75M | 5.71M | 5.68M | 5.73M | 5.64M | 5.61M | 5.65M | 5.59M | 5.63M | 5.63M | 5.64M |
EPS (Basic) | 0.03 | -0.09 | -0.14 | -0.12 | -0.16 | -0.36 | -0.13 | -0.07 | -0.12 | -0.02 | -0.06 | 0.01 | -0.29 | 0.13 | 0.02 | 0.01 |
EPS (Diluted) | 0.03 | -0.09 | -0.14 | -0.12 | -0.16 | -0.36 | -0.13 | -0.07 | -0.12 | -0.02 | -0.06 | 0.01 | -0.29 | 0.13 | 0.02 | 0.01 |
EBITDA | 584K | -595K | -235K | -21K | -284K | -422K | 279K | 186K | 406K | 452K | 525K | 850K | -1.2M | 1.86M | 1.12M | 1.03M |
EBIT | 171K | -595K | -899K | -567K | -868K | -1.11M | -417K | -528K | -356K | -375K | -342K | -10K | -965K | 850K | 207K | 117K |
Depreciation & Amortization | 413K | n/a | 664K | 551K | 575K | 685K | 696K | 714K | 762K | 827K | 867K | 860K | 859K | 1.01M | 912K | 911K |